Please login to the form below
Bluebird puts €1.57m price on gene therapy Zynteglo
US biotech pioneering outcomes-based payment in Europe
Digital division NHSX looks to improve experience for doctors as well as patients
Patient and public buy-in for data use essential
£1 billion cuts to public health must be reversed, say charities
Cuts already having impact
Orkambi row: government now considering Crown Use licensing
MPs call for radical solutions as deadlock remains
Type 1 diabetes prevention promise sends Provention Bio soaring
Remarkable results prompt firm to consider regulatory pathway
Trump backtracks on ‘NHS on the table’ comments
Echoes mixed message at home about healthcare
Roche Diagnostics among beneficiaries as NHS fast-tracks more tech
AHSNs will be responsible for regional uptake
Hancock says “NHS not for sale” in post-Brexit US trade talks
Tensions rise as President Trump arrives for state visit
The shifting healthcare landscape
-
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
The state of trustRoche’s Future-proofing Healthcare event shows how the current model is a complicated one
-
UK pharma’s hard-to-recruit posts need foreign recruitment boostPost-Brexit immigration policy still unclear
-
Countries hail ‘landmark’ drug pricing transparency resolution, despite watering downUS among those in favour of price transparency
-
Deal or no deal? Brexit battlelines drawn in Tory leadership bidsPharma industry warns again on no-deal impact
-
Novartis secures US approval - and payers’ blessing – for $2m gene therapy ZolgensmaNovel financing deal could be sector's future
-
European elections: Eurosceptics and Greens rise, but big parties hold onHorse-trading over top jobs now begins
-
Report shows benefits of GP at Hand digital service, but concerns too High levels of user satisfaction, but 'cherry picking' concerns remain
-
NHS England wants money-back guarantee on OrkambiVertex resisting real-world data proposal
-
Paris biocluster appoints Stéphane Roques as new chiefFormer general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
-
Picker appoints new CEOChris Graham to focus on person-centred care
-
EFPIA appoints new director generalNathalie Moll takes up the role from April
-
IFPMA appoints director generalThomas Cueni brings expertise from Interpharma and EFPIA
-
CureVac’s CEO appointed to EC High Level Group
Dr Ingmar Hoerr will advise on Horizon 2020 and future innovation programmes
Latest healthcare appointments
Featured jobs
- Medical Writer/ Senior Medical Writer opportunities – Macclesfie...
-
competitive salary and benefits package
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Senior Medical Writer
-
Salary TBC
Subscribe to our email news alerts
- Rising demand and understaffing puts NHS waiting times up again
- Lucid demonstrates continual investment in its central services with the appointment of its new Head of Talent, Resourcing and HR projects
- Bluebird puts €1.57m price on gene therapy Zynteglo
- Q&A with Raman Sehgal
- Hansoh Pharma shares head skyward after HKEX debut
- GSK joins forces with Doudna’s CRISPR lab
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- What are you doing, Dave?
- Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
- Fake News is Bad for your Health
- Ill informed patients make poor health decisions...
- Secrets of Pharma Advertising
- If the goal of branding is to be different, why do so many Pharma brand ads look the same?...
Quick links
Infographics
